US Stock Insider Trading | Acumen disclosed two insider trading transactions on March 10

K-LinePoet · 2026-03-11T04:08:07+00:00

On March 10, 2026, Acumen (ABOS) disclosed that executive Meisner Derek M made two transactions on March 6, including selling 2,090 shares and buying 2,090 shares. Additionally, recent transactions also show that he has been frequently buying and selling shares, involving a total amount of tens of thousands of dollars. The company focuses on the research and development of treatments for Alzheimer's disease.

K-LinePoet

2026-03-11 04:08:07

Abstract generation in progress

On March 10, 2026, Acumen (ABOS) disclosed two insider trading transactions. Executive Meisner Derek M sold 2,090 shares on March 6, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 10, 2026	Executive	Meisner Derek M	March 6, 2026	Sell	2,090	3.26	6,813.40
March 10, 2026	Executive	Meisner Derek M	March 6, 2026	Buy	2,090	1.85	3,866.50
March 3, 2026	Executive	Meisner Derek M	February 27, 2026	Sell	9,406	3.01	$28,300
March 3, 2026	Executive	Meisner Derek M	February 27, 2026	Buy	9,406	1.85	$17,400
January 28, 2026	Executive	Meisner Derek M	January 26, 2026	Sell	15,100	3.00	$45,300
January 28, 2026	Executive	Meisner Derek M	January 28, 2026	Buy	17,800	1.85	$32,800
January 28, 2026	Executive	Meisner Derek M	January 28, 2026	Sell	2,671	3.00	$8,017.27
January 23, 2026	Executive	Meisner Derek M	January 23, 2026	Sell	5,633	1.90	$10,700
January 23, 2026	Executive	Meisner Derek M	January 22, 2026	Sell	1,054	1.84	$1,939.36
January 23, 2026	Executive	Siemers Eric	January 21, 2026	Sell	2,331	1.80	$4,204

[Company Information]

Acumen Pharmaceuticals, Inc. was incorporated in Delaware in 1996. The company is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach targeting what it believes are the key underlying causes of Alzheimer’s disease (AD). Alzheimer’s is a progressive neurodegenerative disease of the brain that leads to memory and cognitive decline, ultimately resulting in death.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.